Recent updates from adjuvant trials in HR+/HER2- EBC
Nadia Harbeck, MD, PhD
Maximizing Adherence and Persistence via Patient Engagement
Hope S. Rugo, MD, FASCO
High-Risk, HR+/HER2- EBC: Mastering Treatment Selection
Differentiating CDK4/6 Inhibitors in an Evolving European Treatment Landscape for High-Risk HR+/HER2- EBC
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Regimens
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
Jacob Sands, MD
Lori Pierce, MD, FASTRO, FASCO
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Matt Birnholz, MD
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Ana Maria Rosario
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.